Drugs Channel
Topics & Medications
Quicklinks
Related Channels

Afinitor Dosage

Dosage of Afinitor for Kidney Cancer

The recommended dose of Afinitor for advanced renal cell carcinoma (RCC) is 10 mg once daily. If serious or intolerable side effects occur, the drug may need to be stopped or reduced to 5 mg daily. 
 
The recommended dosage for people with mild liver disease is 7.5 mg a day. The dose may be reduced to 5 mg a day if 7.5 mg is not tolerated. The recommended dosage for people with moderate liver disease is 5 mg daily. The dose may be reduced to 2.5 mg a day if 5 mg is not tolerated. People with severe liver disease should be given no more than 2.5 mg of Afinitor a day.
 
Higher or lower amounts may be used in people taking certain medications known to interact with Afinitor.
 

Dosing of Afinitor for Kidney Tumors

The recommended dosage of Afinitor for the treatment of renal angiomyolipoma in people with tuberous sclerosis is 10 mg once a day. People who develop serious or intolerable side effects may need to temporarily stop taking the medicine, or take a lower dose (usually 5 mg a day).
 
Lower doses are normally given to people with liver disease. The recommended dosage for people with mild liver disease is 7.5 mg a day. The dose may be reduced to 5 mg a day if 7.5 mg is not tolerated.
 
The recommended dosage for people with moderate liver disease is 5 mg daily. The dose may be reduced to 2.5 mg a day if 5 mg is not tolerated.
 
People with severe liver disease should be given no more than 2.5 mg of Afinitor a day.
 
Higher or lower amounts may be used in people taking certain medications known to interact with Afinitor.
  
The Zen of Cancer Caregiving - Recharge Your Batteries!

Afinitor Medication Information

Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.